Published in Dermatologica on January 01, 1975
Disturbance of DNA-Synthesis in early psoriasis. Arch Dermatol Res (1977) 0.85
[Penetration kinetics of dehydroepiandrosterone through the erythrocyte membrane (author's transl)]. Arch Dermatol Res (1981) 0.79
Incorporation of 14C-linoleic acid in cerebrosides of psoriatic and normal human skin. Arch Dermatol Res (1981) 0.75
Secondary autoimmune phenomena in the pathogenesis of psoriasis. Arch Dermatol Res (1981) 0.75
Other functions, other genes: alternative activation of antigen-presenting cells. Immunity (1999) 4.15
Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol (1998) 2.17
Alternative versus classical activation of macrophages. Pathobiology (1999) 2.14
Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet (1997) 1.98
Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol (2001) 1.86
[Normal and psoriatic skin surface as observed under a stereoscan electron microscope]. Arch Klin Exp Dermatol (1969) 1.85
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol (2001) 1.67
Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47
Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology (1997) 1.44
Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol (1999) 1.43
Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J (1997) 1.43
[Hair and hair cuticle under a stereoscan electron microscope]. Arch Klin Exp Dermatol (1969) 1.42
Intravascular coagulation necrosis of the skin associated with cryofibrinogenemia, diabetes mellitus, and cardiolipin autoantibodies. J Am Acad Dermatol (1991) 1.39
Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol (1996) 1.38
[Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma]. Hautarzt (1992) 1.38
[Acute generalized exanthematous pustulosis, induced by nystatin]. Hautarzt (1998) 1.38
Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol (1993) 1.36
Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth. Arch Dermatol (1973) 1.31
Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer (1998) 1.28
Colorimetric growth assay for epidermal cell cultures by their crystal violet binding capacity. Arch Dermatol Res (1989) 1.28
Oral retinoids--present status. Br J Dermatol (1980) 1.26
Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol (1992) 1.25
Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology (1997) 1.24
Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br J Dermatol (1983) 1.24
Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus (1997) 1.23
13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol (2000) 1.21
Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res (1995) 1.18
Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol (1999) 1.18
Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer (1997) 1.17
Matting of hair: a multifactorial enigma. Dermatology (2000) 1.16
Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer (1995) 1.15
Dermal and epidermal types of erythema multiforme. A histopathologic study of 24 cases. Arch Dermatol (1974) 1.15
Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis. Arch Dermatol Res (1996) 1.13
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer (1995) 1.12
Hair destroying growth of Corynebacterium tenuis in the so-called trichomycosis axillaris. New findings from scanning electron microscopy. Arch Dermatol (1971) 1.09
Kaposi's sarcoma is an important risk factor for survival in HIV-infected patients independent of CD4+ cell count. AIDS (1999) 1.09
Expression of HLA-DR antigen in skin from patients with psoriasis. J Invest Dermatol (1982) 1.08
Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett (2000) 1.08
Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS (1997) 1.07
The plasma unit membrane. Membrane mediated growth control and its failure in psoriasis. Br J Dermatol (1977) 1.07
Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine. J Biol Chem (1998) 1.06
Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol (2001) 1.05
Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol (1993) 1.04
Non-specific lymphocyte transformation in vitro by nickel acetate. A possible source of errors in lymphocyte transformation test (LLT). J Invest Dermatol (1970) 1.02
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol (1990) 1.02
[Acquired reactive perforating dermatosis. Successful treatment with allopurinol in 2 cases]. Hautarzt (1999) 1.01
[Beneficial effect of oral retinoid in psoriatic hyperproliferation. Autoradiographic studies on involved and non involved skin (author's transl)]. Arch Dermatol Res (1979) 1.00
Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol (1997) 1.00
Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. Am J Dermatopathol (1987) 1.00
[Netherton's syndrome. Ichthyosis-like changes in the skin and trichorrhexis invaginata. Demonstration of pathologically changed cortex keratin in the hair]. Hautarzt (1971) 0.99
Electron microscopic study of bullous pemphigoid. Arch Dermatol (1972) 0.99
Immunologically confirmed disseminated, asymptomatic Encephalitozoon cuniculi infection of the gastrointestinal tract in a patient with AIDS. Clin Infect Dis (1995) 0.99
Ultrastructural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis. Br J Dermatol (1981) 0.98
Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro. Arch Dermatol Res (1990) 0.98
Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res (1998) 0.98
Ultrastructure and cytochemistry of human cutaneous nerves. With special reference to the ultrastructural localization of the specific and nonspecific cholinesterases in human skin. J Invest Dermatol (1973) 0.98
The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology (1998) 0.97
[Treatment of psoriasis using vitamin A, vitamin A acid and oral retinoids]. Hautarzt (1979) 0.97
Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma. J Invest Dermatol (1995) 0.96
Elephantiasis nostras verrucosa: beneficial effect of oral etretinate therapy. Br J Dermatol (1992) 0.96
Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol (1991) 0.95
Fulminant metastatic calcinosis with cutaneous necrosis in a child with end-stage renal disease and tertiary hyperparathyroidism. Br J Dermatol (1996) 0.95
[Oral therapy of psoriasis using two vitamin A acid-derivatives (author's transl)]. Arch Dermatol Forsch (1973) 0.93
Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol (1992) 0.93
Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings. J Cutan Pathol (2007) 0.92
Evidence for phosphorylation of CTP:phosphocholine cytidylyltransferase by multiple proline-directed protein kinases. J Biol Chem (1996) 0.92
The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro. Br J Cancer (2002) 0.92
Treatment of Adamantiades-Behçet disease with systemic interferon alfa. Arch Dermatol (1998) 0.91
Intestinal microsporidiosis in patients with acquired immunodeficiency syndrome--report of three more German cases. Infection (1995) 0.91
Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol (1991) 0.91
Antigen mimicry, epitope spreading and the pathogenesis of pemphigus. Tissue Antigens (2006) 0.91
Metastatic Crohn's disease of the face. J Am Acad Dermatol (1996) 0.91
Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Anticancer Res (1995) 0.91
Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol (1997) 0.91
[Pathogenesis of pemphigus erythematosus. Transformation of a chronic discoid erythematosus in a pemphigus erythematosus (Senear-Usher)]. Arch Dermatol Forsch (1971) 0.91
Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin. J Invest Dermatol (1988) 0.91
Effects of rIFN alpha, beta, and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol (1990) 0.91
Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol (2005) 0.90
Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol (1996) 0.90
Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma. A case-control study of the German Central Malignant Melanoma Registry. Acta Derm Venereol (1997) 0.90
Bodybuilder oleoma. Br J Dermatol (2003) 0.90
Ultrastructural localization and differentiation of membrane-bound ATP utilizing enzymes including adenyl cyclase in normal and psoriatic epidermis. Br J Dermatol (1975) 0.90
Effects of recombinant tumor necrosis factor-alpha on cultured microvascular endothelial cells derived from human dermis. J Invest Dermatol (1990) 0.90
Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res (2000) 0.90
RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol (1998) 0.90
Twenty-eight cases of juvenile-onset Adamantiades-Behçet disease in Germany. Dermatology (1999) 0.90
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer (1995) 0.89
Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment. Spontaneous regression 8 months after discontinuing therapy. Int J Dermatol (1991) 0.89
Magnetic bead RT-PCR: establishment of a new method for detecting circulating melanoma cells. Melanoma Res (2002) 0.89
Merkel cells as human cutaneous neuroreceptor cells. Their presence in dermal neural corpuscles and in the external hair root sheath of human adult skin. Arch Dermatol Forsch (1974) 0.89
Mechanisms of action of phospholipid analogs as anticancer compounds. Prog Lipid Res (1999) 0.89